At a glance
ClinicalIndex Comparison RecordN/ACompleted· 148 enrolled
Drug / intervention
Persona TM Tibiadevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Persona® TM Tibia Clinical Outcomes Study: Prospective Multicenter Study of the Persona® Trabecular Metal Tibia
In Brief
A clinical study evaluating Persona TM Tibia for Osteoarthritis and 6 related conditions. Completed, enrolled 148 participants across 7 sites.
Detailed Summary
The primary objective of this study is to evaluate clinical performance for the commercially available Persona TM Tibia used in primary cementless tibia total knee arthroplasty.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis, Polyarthritis, Collagen Disorders and/or Avascular Necrosis of the Femoral Condyle, Post-traumatic Loss of Joint Configuration, Moderate Valgus, Varus, or Flexion Deformities
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartApr 2018
First PostedJul 2018
Primary CompletionNov 2022
TodayJul 2026
First PostedJul 17, 2018
Enrollment StartApr 30, 2018
Primary CompletionNov 30, 2022
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 8.0 years ago
Interventions
Persona TM Tibiadevice
Trabecular Metal tibia used in primary cementless total knee arthroplasty